CN103417595A - 一种中药组合物及其制备方法 - Google Patents
一种中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103417595A CN103417595A CN2013104089630A CN201310408963A CN103417595A CN 103417595 A CN103417595 A CN 103417595A CN 2013104089630 A CN2013104089630 A CN 2013104089630A CN 201310408963 A CN201310408963 A CN 201310408963A CN 103417595 A CN103417595 A CN 103417595A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- preparation
- herba
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title abstract description 6
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 206010020772 Hypertension Diseases 0.000 claims abstract description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 95
- 239000000203 mixture Substances 0.000 claims description 89
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 59
- 238000002360 preparation method Methods 0.000 claims description 56
- 239000007788 liquid Substances 0.000 claims description 51
- 241000628997 Flos Species 0.000 claims description 45
- 239000002994 raw material Substances 0.000 claims description 33
- 239000002671 adjuvant Substances 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 235000015091 medicinal tea Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 39
- 208000001953 Hypotension Diseases 0.000 abstract description 11
- 230000036543 hypotension Effects 0.000 abstract description 8
- 231100000331 toxic Toxicity 0.000 abstract description 8
- 230000002588 toxic effect Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 3
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 240000001829 Catharanthus roseus Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 10
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 10
- 238000001694 spray drying Methods 0.000 description 10
- 238000007796 conventional method Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000001631 hypertensive effect Effects 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000002787 reinforcement Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 2
- 229960000830 captopril Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 2
- 229960004569 indapamide Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229960000715 nimodipine Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 239000003087 receptor blocking agent Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010001682 Alkalosis hypochloraemic Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000842328 Bidens bipinnata Species 0.000 description 1
- 239000005537 C09CA07 - Telmisartan Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010024305 Leukaemia monocytic Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010031127 Orthostatic hypotension Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 201000006894 monocytic leukemia Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960005187 telmisartan Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310408963.0A CN103417595B (zh) | 2013-09-10 | 2013-09-10 | 一种中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310408963.0A CN103417595B (zh) | 2013-09-10 | 2013-09-10 | 一种中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103417595A true CN103417595A (zh) | 2013-12-04 |
CN103417595B CN103417595B (zh) | 2015-03-18 |
Family
ID=49643337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310408963.0A Expired - Fee Related CN103417595B (zh) | 2013-09-10 | 2013-09-10 | 一种中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103417595B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690684A (zh) * | 2013-12-10 | 2014-04-02 | 曾瑞光 | 一种治疗高血压及脑血管硬化的青草药沐足粉 |
CN105012618A (zh) * | 2015-07-05 | 2015-11-04 | 杨秀莲 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178761A (zh) * | 2011-05-12 | 2011-09-14 | 于忠敏 | 伍味调压稳压方剂 |
-
2013
- 2013-09-10 CN CN201310408963.0A patent/CN103417595B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178761A (zh) * | 2011-05-12 | 2011-09-14 | 于忠敏 | 伍味调压稳压方剂 |
Non-Patent Citations (1)
Title |
---|
中医研究院西苑医院心血管病研究组: "长春花浓缩浸膏治疗高血压病近期疗效观察", 《新医药学杂志》, no. 03, 31 December 1974 (1974-12-31) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690684A (zh) * | 2013-12-10 | 2014-04-02 | 曾瑞光 | 一种治疗高血压及脑血管硬化的青草药沐足粉 |
CN105012618A (zh) * | 2015-07-05 | 2015-11-04 | 杨秀莲 | 一种治疗胆囊炎的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103417595B (zh) | 2015-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101347528B (zh) | 抗心脑血管疾病的中药组合物 | |
CN100366280C (zh) | 一种治疗高血压的药物组合物及其制备方法和用途 | |
CN102988821B (zh) | 一种治疗癌病手术、化疗、放疗后的中药组合物及其制备方法 | |
CN1931261B (zh) | 一种降压降脂胶囊及其制备方法 | |
CN109498785A (zh) | 健脾祛湿中药组合物 | |
CN102526498A (zh) | 治疗鼻咽癌放疗后毒副作用的中药、制备方法及给药方式 | |
CN101195016B (zh) | 一种治疗中风病的药物及其制备工艺 | |
CN103417595B (zh) | 一种中药组合物及其制备方法 | |
CN108619355A (zh) | 一种抗肿瘤中药组合物及其制备方法 | |
CN102579610B (zh) | 一种治疗脑出血的中药组合物及其制备方法 | |
CN105641344A (zh) | 一种用于治疗便秘的药物制剂及其用途和制备方法 | |
CN103071060B (zh) | 一种治疗强直性脊柱炎的中药制剂 | |
CN102641357B (zh) | 一种治疗高血压的药物及其制备方法 | |
CN105250494A (zh) | 一种改善糖代谢中药配方及制备工艺 | |
CN103417911A (zh) | 化疗辅助用中药组合物 | |
CN103041233A (zh) | 一种治疗小儿腹泻的药物组合物及其制备方法 | |
CN101983666A (zh) | 一种治疗风湿病的中药组合物及其制备方法 | |
CN107913315A (zh) | 一种治疗难治性高血压的中药组合物及其制备方法 | |
CN102233055B (zh) | 一种治疗脑中风的药物组合物及其制备方法 | |
CN103768349A (zh) | 四味大果木姜子制剂在制备治疗脑血管及相关疾病药物中的应用 | |
CN101028392B (zh) | 一种治疗高脂血症的中成药 | |
CN101214302A (zh) | 一组治疗抑郁症伴生功能性消化不良的药物组合物及制法 | |
CN101612304A (zh) | 一种治疗冠心病及脑供血不足的中药复方制剂及制备方法 | |
CN105343688A (zh) | 一种治疗心肌梗塞的药物组合物及其应用 | |
CN105477384A (zh) | 一种降低血压的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170417 Address after: 570216 Hainan South Road, Haikou, No. 168, Haikou Free Trade Zone Patentee after: HAINAN XINSHITONG PHARMACEUTICAL CO.,LTD. Address before: 570216 Hainan South Road, Haikou, No. 168, Haikou Free Trade Zone Patentee before: Cai Lun |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicine composition and its preparing method Effective date of registration: 20180116 Granted publication date: 20150318 Pledgee: Haikou Rural Credit Cooperative Association|Ledong Li Autonomous County Rural Credit Cooperatives|Five Fingers Group Rural Credit Cooperative Association|Rural credit cooperative association of Lingshui Li Nationality Autonomous County Pledgor: HAINAN XINSHITONG PHARMACEUTICAL CO.,LTD. Registration number: 2018460000001 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200811 Granted publication date: 20150318 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230811 Granted publication date: 20150318 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150318 |